View Older Stories View More Recent Stories

Dec 6, 2016 06:03AM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, LLC
Nov 28, 2016 08:00AM Synthorx Appoints Patrick J. Doyle as Chief Business Officer
Nov 23, 2016 07:24PM Form 4 KalVista Pharmaceuticals For: Nov 21 Filed by: RA CAPITAL MANAGEMENT, LLC
Nov 14, 2016 05:18PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Sep 30
Nov 9, 2016 04:32PM Form SC 13D Ra Pharmaceuticals, Inc. Filed by: RA CAPITAL MANAGEMENT, LLC
Nov 1, 2016 03:00AM Biohaven Secures $80 Million in Oversubscribed Private Financing to Advance Phase 3 Clinical Trials
Nov 1, 2016 03:00AM Biohaven Secures $80 Million in Oversubscribed Private Financing to Advance Phase 3 Clinical Trials
Oct 31, 2016 07:42PM Form 4 Ra Pharmaceuticals, Inc. For: Oct 31 Filed by: RA CAPITAL MANAGEMENT, LLC
Oct 26, 2016 02:04PM TiGenix publishes transparency notifications pursuant to Article 14 of the Law of May 2, 2007
Oct 26, 2016 02:00PM TiGenix publishes transparency notifications pursuant to Article 14 of the Law of May 2, 2007
Oct 21, 2016 04:32PM Form SC 13G/A ALCOBRA LTD. Filed by: RA CAPITAL MANAGEMENT, LLC
Oct 6, 2016 04:30PM Form SC 13G/A Aclaris Therapeutics, Filed by: RA CAPITAL MANAGEMENT, LLC
Sep 19, 2016 05:16PM Form 4 Aclaris Therapeutics, For: Sep 15 Filed by: RA CAPITAL MANAGEMENT, LLC
Sep 15, 2016 10:00AM The Economist Presents: "The War on Cancer: Scaling Progress"
Aug 25, 2016 04:16PM Form SC 13G Protagonist Therapeutics Filed by: RA CAPITAL MANAGEMENT, LLC
Aug 15, 2016 04:31PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Jun 30
Aug 15, 2016 04:30PM Form SC 13G Vitae Pharmaceuticals, Filed by: RA CAPITAL MANAGEMENT, LLC
Aug 12, 2016 07:30AM Arrowhead Pharmaceuticals Closes $45 Million Private Offering
Aug 11, 2016 02:51AM KalVista Announces Initiation of a Phase 1 Clinical Trial of KVD818 for the Treatment of Hereditary Angioedema
Jul 28, 2016 04:33PM Form SC 13G ARDELYX, INC. Filed by: RA CAPITAL MANAGEMENT, LLC
Jul 20, 2016 12:00AM Synthorx Announces $10 Million Series B Financing to Develop and Scale Novel Protein Therapeutics with Improved Pharmacological Properties
Jul 15, 2016 12:58PM Unusual 11 Mid-Day Movers 7/15: (OPTT) (JCTCF) (ITI) Higher; (CYTR) (FMSA) (GBSN) Lower
Jul 15, 2016 08:01AM Ardelyx (ARDX) Enters $110M Private Placement
Jul 15, 2016 08:00AM Ardelyx to Raise $110 Million in a Private Placement
Jun 24, 2016 02:03PM Bay Area Lyme Foundation Announces Finalists of "Lyme Innovation" Hackathon
Jun 15, 2016 09:40AM Notable Mergers and Acquisitions 6/15: (EBIX)/(PN) (AEGR)/(QLTI) (DYN) (CBYL) (BBBY)
Jun 15, 2016 07:31AM Carbylan Therapeutics (CBYL) Enters Merger Agreement with Privately-Held KalVista
Jun 15, 2016 07:30AM Carbylan Therapeutics, Inc. and KalVista Pharmaceuticals Ltd. Enter into Share Purchase Agreement
Jun 7, 2016 04:53PM Form SC 13G/A Ascendis Pharma A/S Filed by: RA CAPITAL MANAGEMENT, LLC
Jun 1, 2016 09:00AM Antera Raises $1.7M to Help Infants At Risk of Developing Food Allergies
May 19, 2016 04:00AM KalVista Pharmaceuticals to Support Global Conference Focused on Hereditary Angioedema
May 17, 2016 10:29AM Peregrine Communications Expands US Footprint with Suite of New Clients, Key Business Advisors and the Appointment of a New Senior Hire to Bolster Growth
May 16, 2016 05:10PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Mar 31
Apr 13, 2016 08:00AM Kala Pharmaceuticals Announces Closing of $68 Million Series C Financing
Mar 22, 2016 08:20PM Eiger BioPharmaceuticals Closes Merger With Celladon
Feb 16, 2016 04:50PM Form 13F-HR RA CAPITAL MANAGEMENT, For: Dec 31
Feb 16, 2016 04:35PM Form SC 13G/A Xencor Inc Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 16, 2016 04:35PM Form SC 13G/A ACADIA PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 16, 2016 04:35PM Form SC 13G/A SCYNEXIS INC Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 16, 2016 04:35PM Form SC 13G/A Arbutus Biopharma Corp Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 16, 2016 04:35PM Form SC 13G/A AGILE THERAPEUTICS INC Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 16, 2016 04:35PM Form SC 13G/A DYNAVAX TECHNOLOGIES Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 16, 2016 04:35PM Form SC 13G/A TREVENA INC Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 16, 2016 04:35PM Form SC 13G/A VICAL INC Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 16, 2016 04:34PM Form SC 13G/A WaferGen Bio-systems, Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 16, 2016 04:34PM Form SC 13G/A Aclaris Therapeutics, Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 16, 2016 04:34PM Form SC 13G/A Cidara Therapeutics, Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 16, 2016 04:34PM Form SC 13G/A BIOCRYST PHARMACEUTICALS Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 16, 2016 04:33PM Form SC 13G/A Aurinia Pharmaceuticals Filed by: RA CAPITAL MANAGEMENT, LLC
Feb 16, 2016 04:32PM Form SC 13G/A Blueprint Medicines Corp Filed by: RA CAPITAL MANAGEMENT, LLC
View More Recent Stories View Older Stories